Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions in arthritic patients.

I E Buchan1, H A Bird

  • 1Clinical Pharmacology Unit (Rheumatism Research), University of Leeds, Royal Bath Hospital, Harrogate, United Kingdom.

Annals of the Rheumatic Diseases
|October 1, 1991
PubMed
Summary

In rheumatology patients, 55% had potential drug interactions, but only 11% showed clinical signs. Severe arthritis patients have high interaction potential, yet few exhibit symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992-2010).

International journal of obesity (2005)·2013
Same author

Total hip replacement in dancers.

Clinical rheumatology·2013
Same author

"Extreme" or tariff sports: their injuries and their prevention (with particular reference to diving, cheerleading, gymnastics, and figure skating).

Clinical rheumatology·2013
Same author

Hypermobility in dance: asset, not liability.

Clinical rheumatology·2013
Same author

Scoliosis in musicians and dancers.

Clinical rheumatology·2013
Same author

Introductory editorial: a themed issue on performing arts medicine.

Clinical rheumatology·2013

Area of Science:

  • Rheumatology
  • Clinical Pharmacology

Background:

  • Drug interactions pose a significant risk in patients with chronic conditions.
  • Rheumatology patients often manage complex medication regimens.
  • Assessing the clinical relevance of potential drug interactions is crucial.

Purpose of the Study:

  • To review drug treatments in new rheumatology patients.
  • To identify potential drug interactions using the British National Formulary.
  • To evaluate the clinical manifestations of identified drug interactions.

Main Methods:

  • Reviewed drug treatments of 100 consecutive new rheumatology patients.
  • Identified potential drug interactions based on the British National Formulary (September 1989).
  • Assessed clinical and laboratory features of patients with potential drug interactions.

Main Results:

  • Potential drug interactions were identified in 55% of patients.
  • Only 11% of patients displayed clinical manifestations of drug interactions.
  • Observed effects included drug-induced drowsiness (5 patients) and elevated serum creatinine (5 patients).

Conclusions:

  • While severe arthritis patients have a high potential for drug interactions, the incidence of clinical manifestations is low.
  • Most identified drug interactions did not lead to significant clinical problems.
  • Clinical monitoring is essential, but overt drug interaction symptoms are infrequent in this cohort.

Related Experiment Videos